See other companies on Welcome to the Jungle
Bodyport
Digital therapeutics for cardiorenal conditions
- 21-100 employees
- Healthcare
- B2C
- Personal health
- SaaS
- Wellbeing
- SoMa, San Francisco, CA
Jump to section
Company mission
To prevent and ultimately eliminate heart disease by empowering every person with high quality, actionable health information in their home.
Our take
Heart disease remains the leading cause of death in the US, and incurs associated healthcare costs to the tune of over $200 billion annually. Much of it is preventable, and a preventative approach involving frequent, easily accessible health checks may prove lifesaving and ease significant stress on the US healthcare system. This is precisely what Bodyport is hoping to provide, with its remote home monitoring platform which allows users to get immediate access to crucial heart-related bio-measures.
Backing and partnerships for Bodyport come from some high-profile places, including Stanford Medicine and the Y Combinator. This kind of industry and market confidence will likely serve as strong support whilst the company continues developing additional features such as the launch of a virtual cardiac clinic to offer supplementary insights and support users.
In 2022, Bodyport received FDS 510(k) clearance for its Bodyport Cardiac Scale. From here, the company is expanding access and getting closer to its goal of keeping people with fluid management conditions healthier and away from hospitals.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Retirement benefits - Generous 401(k) and regional retirement plans to help you invest in your future
- Healthcare benefits - Medical, dental, and vision insurance for employees and dependents
- Equity benefits - Every employee gets equity, so you are rewarded for your best work.
- Generous vacation - We have a generous PTO policy to help encourage work life balance
- Paid parental leave - Paid family leave for all parents to support you and your family
Funding (last 2 of 4 rounds)
Aug 2020
$11.2m
SERIES A
Feb 2018
$2m
SEED
Total funding: $15.9m
This company has top investors
Leadership
Corey Centen
(President & CTO)Former Senior Systems Engineer at Medtronic. Founder of Atreo Medical and Mobilab Technologies. BSc in Biomedical and Electrical Engineering at McMaster University.
Sarah Smith
(Chief Product Officer)Former Senior Systems Engineer at Medtronic. Co-founder and former COO at Atreo Medical. BSc Engineering at McMaster University.